The online version of this article (https://doi.org/10.1186/s12885-017-3725-3) contains supplementary material, which is available to authorized users.
Colorectal cancer (CRC) is a major global public health problem and the second leading cause of cancer-related death. Mitochondrial dysfunction has long been suspected to be involved in this type of tumorigenesis, as supported by an accumulating body of research evidence. However, little is known about how mitochondrial alterations contribute to tumorigenesis. Mitochondrial biogenesis is a fundamental cellular process required to maintain functional mitochondria and as an adaptive mechanism in response to changing energy requirements. Mitochondrial biogenesis is regulated by peroxisome proliferator-activated receptor gamma coactivator 1-α (PPARGC1A or PGC1α). In this paper, we report a systematic review to summarize current evidence on the role of PGC1α in the initiation and progression of CRC. The aim is to provide a basis for more comprehensive research.
The literature search, data extraction and quality assessment were performed according to the document Guidance on the Conduct of Narrative Synthesis in Systematic Reviews and the PRISMA declaration.
The studies included in this review aimed to evaluate whether increased or decreased PGC1α expression affects the development of CRC. Each article proposes a possible molecular mechanism of action and we create two concept maps.
Our systematic review indicates that altered expression of PGC1α modifies CRC risk. Most studies showed that overexpression of this gene increases CRC risk, while some studies indicated that lower than normal expression levels could increase CRC risk. Thus, various authors propose PGC1α as a good candidate molecular target for cancer therapy. Reducing expression of this gene could help to reduce risk or progression of CRC.
Additional file 1: Table S1. Reasons for exclusion of 22 articles according to abstract and full-text. Table that describes the reasons for exclusion of the selected articles in the first review. Table S2. Full details of the key characteristics of the selected studies. Table that describes the details of the selected articles. (PDF 245 kb)
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:12. CrossRef
Vega P, Valentín F. Cubiella. J Colorectal cancer diagnosis: Pitfalls and opportunities World J Gastrointest Oncol. 2015;7:12.
Abraha I, Giovannini G, Serraino D, Fusco M, Montedori A. Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol. BMJ Open. 2016;6:3.
Smolková K, Plecitá-Hlavatá L, Bellance N, Benard G, Rossignol R, Ježek P. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol. 2011;43:7. CrossRef
Bianchi G, Martella R, Ravera S, Marini C, Capitanio S, Orengo A, et al. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. Oncotarget. 2015;6:14. CrossRef
Ussakli CH, Ebaee A, Binkley J, Brentnall TA, Emond MJ, Rabinovitch PS, et al. Mitochondria and tumor progression in ulcerative colitis. J Natl Cancer Inst. 2013;105:16. CrossRef
Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma? Biochim Biophys Acta Bioenerg. 2011;1807:6.
Jones AWE, Yao Z, Vicencio JM, Karkucinska-Wieckowska A, Szabadkai G. PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. Mitochondrion. 2012;12:1. CrossRef
Mazzanti R, Giulivi C. Coordination of nuclear- and mitochondrial-DNA encoded proteins in cancer and normal colon tissues. Biochim Biophys Acta Bioenerg. 2006;1757:5–6. CrossRef
Shin SW, Yun SH, Park ES, Jeong JS, Kwak JY, Park JI. Overexpression of PGC-1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and acyl-CoA binding protein. Int J Oncol. 2015;46:3. CrossRef
Srivastava S, Barrett JN, Moraes CT. PGC-1α/β upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Hum Mol Genet. 2007;16:8. CrossRef
Villena JA. New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. FEBS J. 2015;282:4. CrossRef
Feilchenfeldt J, Bründler MA, Soravia C, Tötsch M, Meier CA. Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARγ-coactivator 1 (PGC-1). Cancer Lett. 2004;203:1. CrossRef
Bellafante E, et al. PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine. Proc Natl Acad Sci U S A. 2014;111:42. CrossRef
Seale P. Transcriptional regulatory circuits controlling brown fat development and activation. Diabetes. 2015;64:7. CrossRef
López-Lluch G, Irusta PM, Navas P, De Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008;43:9. CrossRef
Van Gisbergen MW, Voets AM, Starmans MHW, De Cood IFM, Yadakd R, Hoffmanne RF, et al. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat res. Rev Mutat Res. 2015;764:16–30. CrossRef
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Biostats. 1995;536(22):3.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA GROUP. Preferred Reporting. Items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;6(7):264–9. CrossRef
D’Errico I, Salvatore L, Murzilli S, Lo Sasso G, Latorrec D, Martelli N, et al. Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1alpha) is a metabolic regulator of intestinal epithelial cell fate. Proc Natl Acad Sci U S A. 2011;108:16. CrossRef
Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang H, et al. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res. 2011;71:21. CrossRef
Wu F, Wang J, Wang Y, Kwok TT, Kong SK, Wong C. Estrogen-related receptor α (ERRα) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells. Chem Biol Interact. 2009;181:2. CrossRef
Fisher KW, Das B, Seok Kim H, Clymer BK, Gehring D, Smith DR, et al. AMPK Promotes Aberrant PGC1β Expression to Support Human Colon Tumor Cell Survival. 2015;35:22.
D’Errico I, Lo Sasso G, Salvatore L, Murzilli S, Martelli N, Cristofaro M, et al. Bax is necessary for PGC1α pro-apoptotic effect in colorectal cancer cells. Cell Cycle. 2011;10:17.
Kong X, Fan H, Liu X, Wang R, Liang J, Gupta N, et al. Peroxisome proliferator-activated receptor gamma Coactivator-1 alpha enhances Antiproliferative activity of 5Ј-Deoxy-5-Fluorouridine in cancer cells through induction of uridine phosphorylase. Mol Pharmacol. 2009;76:4. CrossRef
Vellinga TT, Borovski T, de Boer VCJ, Fatrai S, Van Schelven S, Trumpi K, et al. SIRT1/PGC1a-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer. Clin Cancer Res. 2015;21:12. CrossRef
Gaustadnes M, Ørntoft TF, Jensen JL, Torring N. Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs. Hum Mutat. 2006;27:2. CrossRef
DeCensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res. 2010;3:1451–61. CrossRef
- Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
Fernanda de Souza-Teixeira
Antonio J. Molina
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II